Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionAperio Group, LLC
Latest Disclosed Ownership175,611 shares
Latest Disclosed Value $ 41,504,000
Aperio Group, LLC reports 6.03% decrease in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On February 5, 2021 - Aperio Group, LLC filed a 13F-HR form disclosing ownership of 175,611 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $41,503,904 USD as of December 31, 2020. The entity filed a previous 13F-HR on November 6, 2020 disclosing 186,875 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of -6.03% during the quarter. The current value of the position is $78,468,263 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2021-02-05 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 175,611 -11,264 -6.03 41,504 -18.38 0.1228
2020-11-06 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 186,875 -7,162 -3.69 50,852 -9.73 0.1718
2020-08-13 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 194,037 19,489 11.17 56,331 35.63 0.2081
2020-05-05 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 174,548 30,852 21.47 41,534 32.01 0.1835
2020-02-13 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 143,696 5,705 4.13 31,462 34.57 0.1130
2019-11-06 2019-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 137,991 10,103 7.90 23,379 -0.31 0.0924
2019-07-30 2019-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 127,888 -16,633 -11.51 23,452 -11.78 0.0958
2019-05-13 2019-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 144,521 16,805 13.16 26,584 25.61 0.1147
2019-05-06 2018-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 127,716 8,918 7.51 21,164 -7.57 0.1068
2019-02-14 2018-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 127,768 8,970 21,172
2019-05-06 2018-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 118,798 8,018 7.24 22,897 21.61 0.1011
2018-10-17 2018-09-30 13F VERTEX PHARMACEUTICAL COMMON 92532F100 118,798 8,018 22,897
2019-05-06 2018-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 110,780 2,203 2.03 18,828 6.40 0.0901
2018-07-30 2018-06-30 13F VERTEX PHARMACEUTICAL COMMON 92532F100 110,780 2,203 18,828
2019-05-01 2018-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 108,577 8,246 8.22 17,696 17.69 0.0881
2018-05-08 2018-03-31 13F VERTEX PHARMACEUTICAL COMMON 92532F100 108,577 8,246 17,696
2019-05-01 2017-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 100,331 6,546 6.98 15,036 5.45 0.0776
2018-02-02 2017-12-31 13F VERTEX PHARMACEUTICAL COMMON 92532F100 100,331 6,546 15,036
2019-05-01 2017-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 93,785 9,294 11.00 14,259 30.96 0.0805
2017-10-25 2017-09-30 13F VERTEX PHARMACEUTICAL COMMON 92532F100 93,785 9,294 14,259
2019-04-22 2017-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 84,491 15,777 22.96 10,888 44.90 0.0667
2017-07-18 2017-06-30 13F VERTEX PHARMACEUTICAL COMMON 92532F100 84,491 15,777 10,888
2019-04-22 2017-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 68,714 -1,119 -1.60 7,514 46.04 0.0514
2017-05-05 2017-03-31 13F VERTEX PHARMACEUTICAL COMMON 92532F100 68,714 -1,119 7,514
2019-04-22 2016-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 69,833 -25,865 -27.03 5,145 -38.35 0.0394
2017-02-14 2016-12-31 13F VERTEX PHARMACEUTICAL COMMON 92532F100 69,833 -25,865 5,145
2019-04-12 2016-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 95,698 14,934 18.49 8,346 20.14 0.0604
2016-11-01 2016-09-30 13F VERTEX PHARMACEUTICAL COMMON 92532F100 95,698 14,934 8,346
2019-04-12 2016-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 80,764 12,255 17.89 6,947 27.56 0.0543
2016-08-12 2016-06-30 13F VERTEX PHARMACEUTICAL COMMON 92532F100 80,764 12,255 6,947
2019-04-12 2016-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 68,509 -2,303 -3.25 5,446 -38.88 0.0466
2016-04-28 2016-03-31 13F VERTEX PHARMACEUTICAL COMMON 92532F100 68,509 -2,303 5,446
2016-01-21 2015-12-31 13F VERTEX PHARMACEUTICAL COMMON 92532F100 70,812 2,651 3.89 8,910 25.53 0.0816
2015-10-19 2015-09-30 13F VERTEX PHARMACEUTICAL COMMON 92532F100 68,161 8,207 13.69 7,098 -4.12 0.0722
2015-07-29 2015-06-30 13F VERTEX PHARMACEUTICAL COMMON 92532F100 59,954 7,576 14.46 7,403 19.81 0.0764
2015-04-29 2015-03-31 13F VERTEX PHARMACEUTICAL COMMON 92532F100 52,378 52,378 0.00 6,179 0.0692
2015-01-30 2014-12-31 13F VERTEX PHARMACEUTICAL COMMON 92532F100 0 -40,841 -100.00 0 -100.00
2014-10-21 2014-09-30 13F VERTEX PHARMACEUTICAL COMMON 92532F100 40,841 9,137 28.82 4,587 52.80 0.0620
2014-07-23 2014-06-30 13F VERTEX PHARMACEUTICAL COMMON 92532F100 31,704 6,294 24.77 3,002 67.06 0.0436
2014-04-25 2014-03-31 13F VERTEX PHARMACEUTICAL COMMON 92532F100 25,410 1,797 18.77 0.0253
2014-01-30 2013-12-31 13F VERTEX PHARMACEUTICAL COMMON 92532F100 1,513 -2.01 0.0235
2013-10-24 2013-09-30 13F VERTEX PHARMACEUTICAL COMMON 92532F100 20,370 4,380 27.39 1,544 20.63 0.0298
2013-07-19 2013-06-30 13F VERTEX PHARMACEUTICAL COMMON 92532F100 15,990 15,990 1,280 0.0304
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.